Status: Not yet recruiting
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
This study will evaluate the safety and effectiveness of a single injection of EO2002 at one of two dose levels (150,000 or 500,000 magnetic human corneal endothelial cells \[mHCECs\]), compared with a placebo injection, in participants with corneal edema caused by corneal endothelial dysfunction.
Participants needed: 121
Trial details
Phase: Phase 2Age: 21+Biological sex: AllType: InterventionalSponsor: EmmecellUpdated: Jul 29, 2026Locations: 1
Eligibility criteria
Symptomatic central corneal edema that is primarily responsible for loss of visi... [+4]
Corneal disease in either eye (other than corneal endothelial dysfunction second... [+9]